AR 1012Alternative Names: AR1012
Latest Information Update: 13 Oct 2016
At a glance
- Originator AriBio
- Class Small molecules
- Mechanism of Action Histone deacetylase modulators; Wnt signalling pathway modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Eye disorders; Glaucoma
Most Recent Events
- 01 Jun 2016 Early research in Eye disorders in South Korea (unspecified route)
- 01 Jun 2016 Early research in Glaucoma in South Korea (unspecified route)